Dr Tracy Briggs qualified from the University of Liverpool in 2003 and obtained membership of the Royal College of Paediatrics in 2006, before starting her training in Clinical Genetics in Leeds. After 18 months of training, she obtained a Wellcome Trust Clinical Training Fellowship and worked on the genetics of innate immune disease for three and a half years, through which she gained her PhD at the University of Manchester. Dr Briggs completed her Clinical Genetics training in Manchester and worked as an NIHR Clinical Lecturer for four and a half years. She obtained her Certificate in Medical Genetics Training in 2015 and her Certificate of Completion of Specialist Training (CCST) in Genetic Medicine in August 2016. She was awarded a two-year NIHR Transitional Fellowship in 2016, a Senior Lectureship at the University of Manchester and Honorary Consultant in Genomic Medicine at St Mary's Hospital, Manchester.
Dr Brigg's current research focuses on immunogenetics - defining the genetic factors that regulate the immune system and determining the consequences of a genetic change to human health. She has a particular interest in type I interferon driven diseases and the genetics of rare forms of systemic lupus erythematosus.
Dr Brigg's main clinical interest relates to her research interest and she is leading a natural history study to review individuals annually with a group of genetic disorders in which interferon regulation is altered (type I interferonopathies).
She sees patients with various immune problems, caused by either an over activation (autoimmune or autoinflammatory disease) or under activity (immunodeficiency) and she works closely with colleagues in the fields of immunology, rheumatology and neurology at the Royal Manchester Children's Hospital and Manchester Royal Infirmary.
Type I interferon, developmental medicine